(Alumnus) Hirofumi Yoshino, MD, PhD
Current: Stuff Scientist at University of Kagoshima
2013-2015 Postdoctoral fellow, Department of Internal Medicine, Division of Hematology &
Oncology, University of Cincinnati, College of Medicine
2015- Medical staff, Department of Urology, Graduate School of Medical and Dental
Sciences, Kagoshima University, Japan
Sumita K, Lo YH, Takeuchi K, Senda M, Kofuji S, Ikeda Y, Terakawa J, Sasaki M, Yoshino H, Majd N, Zheng Y, Kahoud ER, Yokota T, Emerling BM, Asara JM, Ishida T, Locasale JW, Daikoku T, Anastasiou D, Senda T, Sasaki AT.
The lipid kinase PI5P4Kβ is an intracellular GTP sensor for metabolism and tumorigenesis.
Molecular Cell 2016; 61:1-12.
Majd N, Sumita K, Yoshino H, Chen D, Terakawa J, Daikoku T, Kofuji S, Curry R, Wise-Draper T, Warnick RE, Guarnaschelli J and Sasaki AT.
A Review of the Potential Utility of Mycophenolate Mofetil as a Cancer Therapeutic.
Journal of Cancer Research 2014; 423401.
Sumita K, Yoshino H, Sasaki M, Majd N, Kahoud ER, Takahashi H, Takeuchi K, Kuroda T, Lee S, Charest PG, Takeda K, Asara JM, Firtel RA, Anastasiou D, Sasaki AT.
Degaradation of Activated K-Ras Orthologue via K-Ras Specific Lysine Residues is Required for Cytokinesis.
J Biol Chem. 2014;289(7):3950-9. |
------
1. Chiyomaru T, Yamamura S, Fukuhara S,
Yoshino H, Kinoshita T, Majid S, Saini S, Chang I, Tanaka Y, Enokida H, Seki N, Nakagawa M, Dahiya R. Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR.
PLoS One. 2013;8:e70372.
2. Yamasaki T, Seki N,
Yoshino H, Itesako T, Yamada Y, Tatarano S, Hidaka H, Yonezawa T, Nakagawa M, Enokida H. Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 (GLUT1) in renal cell carcinoma.
Cancer Sci. 2013 Jul 25.
3.
Yoshino H, Seki N, Itesako T, Chiyomaru T, Nakagawa M, Enokida H. Aberrant expression of microRNAs in bladder cancer.
Nat Rev Urol. 2013;10:396-404.
4.
Yoshino H, Enokida H, Itesako T, Tatarano S, Kinoshita T, Fuse M, Kojima S, Nakagawa M, Seki N. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
J Hum Genet. 2013 May 2.
5. Nohata N, Hanazawa T, Kinoshita T, Inamine A, Kikkawa N, Itesako T,
Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N. Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.
Br J Cancer. 2013;108:1648-58.
6. Yamamoto N, Kinoshita T, Nohata N, Itesako T,
Yoshino H, Enokida H, Nakagawa M, Shozu M, Seki N. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.
Int J Oncol. 2013;42:1523-32.
7 Yamasaki T, Seki N,
Yoshino H, Itesako T, Hidaka H, Yamada Y, Tatarano S, Yonezawa T, Kinoshita T, Nakagawa M, Enokida H. MicroRNA-218 Inhibits Cell Migration and Invasion in Renal Cell Carcinoma through Targeting Caveolin-2 Involved in Focal Adhesion Pathway.
J Urol. 2013;190:1059-68.
8. Nishimura H, Enokida H, Tsuruta M,
Yoshino Y, Yamada Y, Sugita S, Hayashi S, Arata K, Hayami H, Nishiyama K, Nakagawa M. Combination treatment using percutaneous transluminal angioplasty and low-density lipoprotein apheresis in a patient with peripheral arterial disease and a history of chronic hemodialysis.
J Clin Apher. 2013;28:330-4.
9. Yamada Y, Hidaka H, Seki N,
Yoshino H, Yamasaki T, Itesako T, Nakagawa M, Enokida H. Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.
Cancer Sci. 2013;104:304-12.
10. Kinoshita T, Hanazawa T, Nohata N, Kikkawa N, Enokida H,
Yoshino H, Yamasaki T, Hidaka H, Nakagawa M, Okamoto Y, Seki N. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.
Oncotarget. 2012;3:1386-400.
11 Fuse M, Kojima S, Enokida H, Chiyomaru T,
Yoshino H, Nohata N, Kinoshita T, Sakamoto S, Naya Y, Nakagawa M, Ichikawa T, Seki N. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
J Hum Genet. 2011;57:691-9.
12. Yamasaki T, Seki N, Yamada Y,
Yoshino H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Nakagawa M, Enokida H. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
Int J Oncol. 2012;41:805-17.
13 Yamasaki T,
Yoshino H, Enokida H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Fuse M, Seki N, Nakagawa M. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.
Int J Oncol. 2012;40:1821-30.
14. Kinoshita T, Nohata N, Watanabe-Takano H,
Yoshino H, Hidaka H, Fujimura L, Fuse M, Yamasaki T, Enokida H, Nakagawa M, Hanazawa T, Okamoto Y, Seki N. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.
Int J Oncol. 2012;40:1770-8.
15 Hidaka H, Seki N,
Yoshino H, Yamasaki T, Yamada Y, Nohata N, Fuse M, Nakagawa M, Enokida H. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.
Oncotarget. 2012;3:44-57.
16. Kinoshita T, Nohata N, Fuse M, Hanazawa T, Kikkawa N, Fujimura L, Watanabe-Takano H, Yamada Y,
Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
Biochem Biophys Res Commun. 2012;418:378-83.
17 Tatarano S, Chiyomaru T, Kawakami K, Enokida H,
Yoshino H, Hidaka H, Nohata N, Yamasaki T, Gotanda T, Tachiwada T, Seki N, Nakagawa M. Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.
Int J Oncol. 2012;40:951-9.
18.
Yoshino H, Enokida H, Chiyomaru T, Tatarano S, Hidaka H, Yamasaki T, Gotannda T, Tachiwada T, Nohata N, Yamane T, Seki N, Nakagawa M. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.
Biochem Biophys Res Commun. 2012;417:588-93.
19. Kojima S, Chiyomaru T, Kawakami K,
Yoshino H, Enokida H, Nohata N, Fuse M, Ichikawa T, Naya Y, Nakagawa M, Seki N. Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer.
Br J Cancer. 2012;106:405-13.
20. Kinoshita T, Nohata N,
Yoshino H, Hanazawa T, Kikkawa N, Fujimura L, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, Okamoto Y, Seki N. Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma.
Int J Oncol. 2012;40:185-93.
21. Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Fujimura L, Chiyomaru T, Kawakami K,
Yoshino H, Enokida H, Nakagawa M, Katayama A, Harabuchi Y, Okamoto Y, Seki N. Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma.
Br J Cancer. 2011;105:833-41.
22. Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Sakurai D, Fujimura L, Kawakami K, Chiyomaru T,
Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).
J Hum Genet. 2011;56:595-601.
23. Kawakami K, Enokida H, Chiyomaru T, Tatarano S,
Yoshino H, Kagara I, Gotanda T, Tachiwada T, Nishiyama K, Nohata N, Seki N, Nakagawa M. The functional significance of miR-1 and miR-133a in renal cell carcinoma.
Eur J Cancer. 2012;48:827-36.
24. Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Sasaki K, Chiyomaru T, Kawakami K,
Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N.. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma.
Int J Oncol. 2011;39:1099-107.
25. Tatarano S, Chiyomaru T, Kawakami K, Enokida H,
Yoshino H, Hidaka H, Yamasaki T, Kawahara K, Nishiyama K, Seki N, Nakagawa M. miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.
Int J Oncol. 2011;39:13-21.
26. Yoshitomi T, Kawakami K, Enokida H, Chiyomaru T, Kagara I, Tatarano S,
Yoshino H, Arimura H, Nishiyama K, Seki N, Nakagawa M. Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.
Oncol Rep. 2011; 25:1661-8.
27. Nohata N, Sone Y, Hanazawa T, Fuse M, Kikkawa N,
Yoshino H, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, Shozu M, Okamoto Y, Seki N. miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma.
Oncotarget. 2011;2:29-42.
28. Chiyomaru T, Tatarano S, Kawakami K, Enokida H,
Yoshino H, Nohata N, Fuse M, Seki N, Nakagawa M. SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer.
Prostate. 2011;25:10.1002.
29.
Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N, Nakagawa M. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.
Br J Cancer. 2011;104:808-818.
30. Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, Tatarano S,
Yoshino H, Kawahara K, Nishiyama K, Seki N, Nakagawa M. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology.
Cancer Sci. 2011;102:522-9.
31. Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Fujimura L,
Yoshino H, Kawakami K, Chiyomaru T, Enokida H, Nakagawa M, Okamoto Y, Seki N. Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma.
Int J Oncol. 2011;38:209-17.
32. Matsuda R, Enokida H, Chiyomaru T, Kikkawa N, Sugimoto T, Kawakami K, Tatarano S,
Yoshino H, Toki K, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M. LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling.
Br J Cancer. 2011;104:376-86.
33. Toki K, Enokida H, Kawakami K, Chiyomaru T, Tatarano S,
Yoshino H, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M. CpG hypermethylation of cellular retinol-binding protein 1 contributes to cell proliferation and migration in bladder cancer.
Int J Oncol. 2010;37:1379-88.
和文
1.
吉野裕史, 他3 名.1 番目.マイクロRNA発現プロファイルを起点とした膀胱癌における分子ネットワークの